Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Labcorp Holdings ( (LH) ).
Labcorp Holdings Inc. reported that on January 28, 2026, it executed a second amendment to its receivables purchase agreement through its special-purpose entity, Labcorp Receivables LLC, with PNC Bank as administrative agent and other parties. The amendment extended the facility’s scheduled termination date to January 26, 2029, added a committed $125 million accordion feature that allows Labcorp Receivables to increase the facility size from $700 million to up to $825 million by May 29, 2026, and removed a 0.10% SOFR adjustment previously applied to the capital accruing yield. The structure keeps Labcorp Receivables as a separate legal entity whose assets are available first to its own creditors, with any excess collections potentially remitted to Labcorp, underscoring the company’s continued use of off-balance-sheet-like receivables financing to enhance liquidity while maintaining creditor protections.
The most recent analyst rating on (LH) stock is a Buy with a $291.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
The score is driven primarily by solid financial performance (notably strong cash flow) and a positive earnings outlook with raised free-cash-flow guidance. These strengths are tempered by softer technical momentum (negative MACD and trading below key moving averages) and a valuation that is reasonable but not notably cheap.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. operates in the healthcare diagnostics sector, providing laboratory testing and related services, including clinical lab and pathology testing, to healthcare providers, pharmaceutical companies and patients across various markets. The company uses structured receivables financing through a special-purpose entity, Labcorp Receivables LLC, to support its working capital and liquidity needs while legally separating certain receivables from its broader corporate balance sheet.
Average Trading Volume: 831,807
Technical Sentiment Signal: Strong Buy
Current Market Cap: $22.48B
For detailed information about LH stock, go to TipRanks’ Stock Analysis page.